Risk, returns & timeframes illustration
1 min read
April 6, 2022
by

Are companies saying IP-nope?

Looks like 2021’s bright light IPO-bonanza has fizzled out. 💨 What could be causing investor uncertainty and could it last forever? Get the downlow on IPOs.
1 min read
April 6, 2022
by

Are companies saying IP-nope?

Looks like 2021’s bright light IPO-bonanza has fizzled out. 💨 What could be causing investor uncertainty and could it last forever? Get the downlow on IPOs.
1 min read
April 6, 2022
by

Are companies saying IP-nope?

Looks like 2021’s bright light IPO-bonanza has fizzled out. 💨 What could be causing investor uncertainty and could it last forever? Get the downlow on IPOs.
Table of contents
Getting Started Investing course
Free Getting Started Course
Take your first, or next, step to becoming a confident investor with Hatch's free online course – just 10 minutes a day, for 10 days.

It’s not just the Highlanders suffering a recent dry spell. After a winning performance in 2021, the rate of new Initial Public Offerings (IPOs) in the first quarter of 2022 has well and truly been kicked into touch. 🏉 Based on listings tracked by Renaissance Capital, the first three months of 2022 was the slowest first quarter for companies going public in six years, with just 18 IPOs raising a mere US$2.1 billion. That is 95% down on last year and not even enough to cover the cost of Auckland’s new City Rail Link. 🚈

Last year new listings were partying like it was 1999 (also the last time the Highlanders reached a Super Rugby final 😢). When buy-now-pay-later company Affirm (AFRM) listed in January 2021, their share price jumped 90% on opening day, while Bumble (BMBL) shares soared 64% after listing. So why are companies saying nope to the IPO? 

Despite the stonks start last year, the share price of many big IPOs dropped back in late 2021 as inflation roared higher. Uncertainty has continued growing in 2022, with pressure from interest rates and Russia's war with Ukraine making investors more cautious and valuations tricky. The Renaissance IPO ETF (IPO), which tracks IPO performance and includes holdings in big tech listings, including Uber (UBER), Snowflake (SNOW) and CrowdStrike (CRWD), had its worst first quarter since 2011, dropping 24%, well below the S&P 500’s 5% loss. Companies that were previously considering listing, including Stripe and Instacart, have also had their valuations cut. ✂️

Another reason could simply be that the boom of 2021 brought new listings forward. The 397 IPOs in 2021 was more than all of 2019 and 2020 combined. So just like that mountain of toilet paper we panic bought and are still working our way through (no…? just us? 🧻), there could be a lull before a fresh team of IPOs are ready to kick-off.

We’re not financial advisors and Hatch news is for your information only. However dazzling our writing, none of it is a recommendation to invest in any of the companies or funds mentioned. If you want support before making any investment decisions, consider seeking financial advice from a licensed provider. We’ve done our best to ensure all information is current when we pushed ‘publish’ on this article. And of course, with investing, your money isn’t guaranteed to grow and there’s always a risk you might lose money.

Join the Kiwis who are hatching their tomorrow and have invested more than $1 billion with Hatch.

Explore another series
Tax
Money
Economy
Investing

More recent news articles

Recent learn articles

7 min read
Apr 15, 2025

EV market rising but Tesla sales decline

Predicted by some to become a US $1.58 trillion dollar market globally, in the US alone EV sales are up 11.4% year-over-year. Which countries are leading the fast-charge? And how could trade tariffs impact sales as we accelerate into the second quarter?
Read more
8 min read
Mar 25, 2025

What’s driving gold prices to record highs?

As the world waits for Trump’s tariffs policies to take effect, the allure of gold has sent bullion, stocks and ETFs to glittering highs. But could gold’s volatility and the potential for the US to sell its gold reserves to buy bitcoin prime other global central banks to do the same?
Read more
8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more

Related news articles

More recent learn articles

No items found.

Recent news articles

More recent learn articles

7 min read
Apr 15, 2025

EV market rising but Tesla sales decline

Predicted by some to become a US $1.58 trillion dollar market globally, in the US alone EV sales are up 11.4% year-over-year. Which countries are leading the fast-charge? And how could trade tariffs impact sales as we accelerate into the second quarter?
Read more
8 min read
Mar 25, 2025

What’s driving gold prices to record highs?

As the world waits for Trump’s tariffs policies to take effect, the allure of gold has sent bullion, stocks and ETFs to glittering highs. But could gold’s volatility and the potential for the US to sell its gold reserves to buy bitcoin prime other global central banks to do the same?
Read more
8 min read
Mar 4, 2025

Can Biotech beat cancer?

Some Kiwi companies are making significant advances in cancer diagnosis and treatment that could save lives worldwide. Global pharmaceutical companies are also making huge strides in cancer clinical trials, but could Trump’s administration derail decades of research?
Read more